Found 18 matching trials
Circulating B-cell, Drug and Anti-drug Antibodies Monitoring in Patients Treated With Rituximab for Autoimmune Disorders N/A The MONIRITUX study aimed to evaluate whether monitoring (i) circulating B-...
Show More Learn More & Join Trial
Therapeutic Drug Monitoring of Secukinumab in Psoriasis Patients. PHASE4 Biologics such as secukinumab are currently the most effective treatment op...
Show More Location
AZ Maria Middelares
Learn More & Join Trial
Therapeutic Drug Monitoring of Risankizumab in Psoriasis Patients (BIOLOPTIM-RIS) PHASE4 Biologics such as risankizumab are currently the most effective treatment o...
Show More Location
AZ Maria Middelares
Learn More & Join Trial
Repertoire and Properties of Anti-drug Antibodies Involved in Immediate Hypersensitivity in the Operating Room NA Acute per-anesthetic hypersensitivity reaction (HSA-PA) is a rapidly occurr...
Show More Location
Hôpital Bichat claude Bernard
Learn More & Join Trial
Therapeutic Drug Monitoring-baSed adalimuMab De-escalatiOn in nOn-infecTious cHronic Uveitis PHASE4 Uveitis and its complications are thought to account for 10 to 15% of preve...
Show More Learn More & Join Trial
BIOTIPRA: BIOmarker-guided Treatment Decisions In Psoriatic and Rheumatoid Arthritis NA TNFi drugs remain the most prescribed first-line biologics for patients wit...
Show More Location
Centre for Musculoskeletal Research
Learn More & Join Trial
3TR (Taxonomy, Treatment, Targets and Remission) Systemic Lupus Erithematosus Study Protocol PHASE3 The natural history of Systemic lupus erythematosus (SLE) is characterized ...
Show More Status
Active Not Recruiting
Learn More & Join Trial
Therapeutic Drug Monitoring of Guselkumab in Psoriasis Patients PHASE4 Biologic such as guselkumab are currently the most effective treatment opti...
Show More Location
AZ Maria Middelares
Learn More & Join Trial
Anti-Biopharmaceutical Immunization: Prediction and Analysis of Clinical Relevance to Minimize the Risk of Immunization in Rheumatoid Arthritis Patients or Juvenile Idiopathic Arthritis Patients NA One of the main potential causes of these failures of BP therapy response i...
Show More Learn More & Join Trial
Evaluating QTc, PK, Safety of Gemtuzumab Ozogamicin (GO) in Patients With CD33+ R/R AML PHASE4 This is a single-arm, open-label, Phase 4 study evaluating the effect of GO...
Show More Location
Augusta University Medical Center Clinical Research Pharmacy
Learn More & Join Trial